Biomerica (BMRA) Enters Service Agreement to Develop IVD Assays

Biomerica Inc. (Nasdaq: BMRA) said on May 29, 2026, it entered into a service agreement to develop in vitro diagnostic (IVD) assays. The financial terms of the deal were not disclosed. The agreement aims to advance the company's diagnostic testing portfolio. Biomerica shares closed at $0.38 on May 28.